ArticleClinical, cosmetic and investigational dermatology2023

Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A.

Li-Li Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.